How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
ABBOTT PARK, Ill., July 19 /PRNewswire-FirstCall/ -- Today Abbott announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its automated, mid-volume hematology instrument, CELL-DYN Ruby(TM). With its advanced laser optics, this instrument offers enhanced cellular analysis and greater efficiency for laboratories performing complete blood counts (CBCs), a test routinely ordered by doctors to assess apatient's overall health and to screen for a variety of disorders such asanemia and infection.
A key facet of CELL-DYN Ruby is its use of laser light to differentiate cellular components. Known as Multi-Angle Polarized Scatter Separation(MAPSS(TM)), this all-optical technology provides detailed results in easy-to-view diagrams, visually depicting changes in white blood cells, red blood cells and platelets. CELL-DYN Ruby also underwent a multi-centermedical evaluation showing clinically equivalent results with CELL-DYN Sapphire(TM), a higher-volume, automated analyzer introduced about this time last year.
To streamline inventory and simplify laboratory operations, CELL-DYN Rubyonly requires four reagents. Additionally, the instrument utilizes advanced yet intuitive software with online tutorials to help facilitate training.
"First pass efficiency has been a hallmark of the CELL-DYN family of analyzers and an important part of improving patient care by providing hematology results quickly," said Harold Flynn , divisional vice president andgeneral manager, hematology, Abbott. "CELL-DYN Ruby further enhances our instrument portfolio by bringing a premium, mid-volume analyzer to support the needs of small to medium-sized hospital laboratories and clinics."
Abbott's full line of automated hematology instruments includes the CELL-DYN Sapphire, CELL-DYN Ruby, CELL-DYN(R) 3700, CELL-DYN(R) 3200,CELL-DYN(R) 1800 and CELL-DYN(R) SMS(TM) [Slide Maker Stainer].